NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

HIV infection and risk behaviour in injecting drug users in Berlin.

Stark K, Muller R, Heinz M, Bellmann G, Guggenmoos-Holzmann I, Bienzle U; International Conference on AIDS.

Int Conf AIDS. 1993 Jun 6-11; 9: 706 (abstract no. PO-C15-2935).

Landesinstitut fur Tropenmedizin, Freie Universitat, Berlin, Germany.

OBJECTIVE: To assess the prevalence of risk behaviour and risk reduction in IDU and the association with HIV serostatus. METHODS: Cross-sectional study in 376 IDU recruited by multisite sampling. Bivariate and multivariate statistical analysis. RESULTS: The overall HIV seroprevalence was 24%. It was much lower in clients of treatment centres as compared to IDU recruited from storefront units and from the street. HIV infection was associated with age, history of injecting, frequency of borrowing syringes, injecting drugs in prison, lifetime IDU partners, sex with HIV+ partners, respectively. Of all IDU, 82% had ever borrowed syringes/needles, 42% within the previous 6 months. Borrowing in the previous 6 months was associated with younger age, a shorter history of injecting, previous drug treatment, and contact to counselling agencies (all p < 0.05). Risk reduction was reported by 63% of the IDU. In this subgroup the HIV seroprevalence was significantly lower. 51% had reduced the frequency of borrowing syringes, only 33% had increased condom use. CONCLUSION: A majority of IDU has reduced risks of HIV infection. However, the prevalence of risk behaviour still is high, especially among IDU of young age and with a short history of injecting.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • Berlin
  • Counseling
  • Cross-Sectional Studies
  • HIV Infections
  • HIV Seropositivity
  • HIV Seroprevalence
  • Humans
  • Prevalence
  • Risk-Taking
  • Substance-Related Disorders
  • Syringes
Other ID:
  • 93336854
UI: 102206233

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov